3 major risks in retirement
3 major risks in retirement

3 major risks in retirement

DSIJ Intelligence Article rating: 5.0

Most of the people depend on EPF balances, NPS balances, annuities, etc. to ride through retirement. However, ignoring the risks that are involved in retirement can create a problem. So, what are those risks? Let’s find out.

Polycab reports stellar numbers, stock shines
Polycab reports stellar numbers, stock shines

Polycab reports stellar numbers, stock shines

Amir Shaikh Article rating: 5.0


Profit after tax in Q2FY20 more than doubled to Rs. 193.8 crore from Rs. 89.5 crore in Q2FY19. Further, the company recorded 222 bps and 778 bps improvement in ROCE and ROE to 26.3 per cent and 22 per cent for Q2FY20 respectively.

Fine Start for Markets Today
Fine Start for Markets Today

Fine Start for Markets Today

DSIJ Intelligence-3 Article rating: 5.0

In the early act, SGX Nifty can be seen marching higher, with global cues being supportive this morning. Further, bulls will take a sigh of relief from the fact that the IMF sees the Indian economic growth, rebounding to around 7 per cent in the next financial year. However, as the day progresses, all eyes will be on the results of the Assembly election, recently held in Haryana and Maharashtra.

Index trend and stocks in action October 24, 2019
Index trend and stocks in action October 24, 2019

Index trend and stocks in action October 24, 2019

DSIJ Intelligence-3 Article rating: 5.0

The level of 11,550 is immediate support for the Nifty and a sustainable move below this can create opportunities for further corrections towards 11,450 level. Meanwhile, the level of 11,700-11,715 poses stiff resistance for Nifty on the upside. Stocks in news: GMR Infrastructure, Yes Bank, HCL Technologies, PVR, Hindustan Aeronautics, DHFL.

U.S. FDA approved Lupin's Divalproex Sodium Extended-Release (ER) Tablets
U.S. FDA approved Lupin's Divalproex Sodium Extended-Release (ER) Tablets

U.S. FDA approved Lupin's Divalproex Sodium Extended-Release (ER) Tablets

DSIJ Intelligence Article rating: 5.0

Lupin Limited received approval for its Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of AbbVie Inc.

Larsen & Toubro awarded by a mega EPCC project
Larsen & Toubro awarded by a mega EPCC project

Larsen & Toubro awarded by a mega EPCC project

DSIJ Intelligence Article rating: 4.0

Larsen and Toubro Hydrocarbon Engineering Limited (LTHE) on Wednesday, has been awarded a mega EPCC project by Hindustan Petroleum Corporation Limited (HPCL). LTHE is a wholly owned subsidiary of Larsen and Toubro.

Market ends in green after a volatile session
Market ends in green after a volatile session

Market ends in green after a volatile session

Nidhi Jani Article rating: 5.0

The BSE Sensex ended at 39058.83, up by 94.99 points or 0.24%. The broader indices ended mixed; the BSE Mid cap index fell 0.18%, while Small cap index was up by 0.24%.

RSS
First31263127312831293131313331343135Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR